<SEC-DOCUMENT>0001104659-22-050961-index.html : 20220427
<SEC-HEADER>0001104659-22-050961.hdr.sgml : 20220427
<ACCEPTANCE-DATETIME>20220427141226
ACCESSION NUMBER:		0001104659-22-050961
CONFORMED SUBMISSION TYPE:	F-1/A
PUBLIC DOCUMENT COUNT:		17
FILED AS OF DATE:		20220427
DATE AS OF CHANGE:		20220427

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BELITE BIO, INC
		CENTRAL INDEX KEY:			0001889109
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		F-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-264134
		FILM NUMBER:		22858735

	BUSINESS ADDRESS:	
		STREET 1:		5820 OBERLIN DRIVE, SUITE 101
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-246-6240

	MAIL ADDRESS:	
		STREET 1:		5820 OBERLIN DRIVE, SUITE 101
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>F-1/A
<SEQUENCE>1
<FILENAME>tm2132809-21_f1a.htm
<DESCRIPTION>F-1/A
<TEXT>
Document 1 - file: tm2132809-21_f1a.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>tm2132809d25_ex23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
Document 2 - file: tm2132809d25_ex23-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>lg_belitebio-4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: lg_belitebio-4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>lg_friedmanllp-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: lg_friedmanllp-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tm2132809d1-fc_beltebw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: tm2132809d1-fc_beltebw.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm2132809d1-ph_proofbwlr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: tm2132809d1-ph_proofbwlr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tm2132809d10-ph_lesion4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 7 - file: tm2132809d10-ph_lesion4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm2132809d4-bc_serum4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 8 - file: tm2132809d4-bc_serum4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>tm2132809d4-lc_dosing4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 9 - file: tm2132809d4-lc_dosing4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>tm2132809d4-lc_optic4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 10 - file: tm2132809d4-lc_optic4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>tm2132809d4-lc_reduct4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 11 - file: tm2132809d4-lc_reduct4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>tm2132809d4-ph_babys4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 12 - file: tm2132809d4-ph_babys4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>tm2132809d4-ph_disease4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 13 - file: tm2132809d4-ph_disease4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>tm2132809d4-ph_lbs4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 14 - file: tm2132809d4-ph_lbs4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>tm2132809d4-ph_segment4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 15 - file: tm2132809d4-ph_segment4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>tm2132809d25_ex23-1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 16 - file: tm2132809d25_ex23-1.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>tm2132809d25_ex23-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 17 - file: tm2132809d25_ex23-1img001.jpg

</DOCUMENT>
</SEC-DOCUMENT>